Pharmaceutical lobby sues Trump administration over most-favored-nation pricing

The pharmaceutical industrys top lobby group on Wednesday sued to invalidate one piece of the Trump administrations efforts to benchmark US drug prices to lower costs overseas in the Medicare health insurance program arguing that it is an illegal overreach by the US government The GLOBE rule intends to set hospital drug prices for Medicare patients Its final version was published last week on exac